These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24311613)

  • 1. High-density lipoprotein: NO failure in heart failure.
    Javaheri A; Rader DJ
    Circ Res; 2013 Dec; 113(12):1275-7. PubMed ID: 24311613
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties.
    Adams V; Besler C; Fischer T; Riwanto M; Noack F; Höllriegel R; Oberbach A; Jehmlich N; Völker U; Winzer EB; Lenk K; Hambrecht R; Schuler G; Linke A; Landmesser U; Erbs S
    Circ Res; 2013 Dec; 113(12):1345-55. PubMed ID: 24055733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise training improves high-density lipoprotein-mediated transcription of proangiogenic microRNA in endothelial cells.
    Riedel S; Radzanowski S; Bowen TS; Werner S; Erbs S; Schuler G; Adams V
    Eur J Prev Cardiol; 2015 Jul; 22(7):899-903. PubMed ID: 24958738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of exercise training on T-wave alternans assessed during exercise test in heart failure patients.
    Piotrowicz E; Pencina M; Piotrowski W; Banach M; Piotrowicz R
    Int J Cardiol; 2014 Jul; 174(3):747-9. PubMed ID: 24767758
    [No Abstract]   [Full Text] [Related]  

  • 5. 'This is a walking test, not a talking test': the six minute walking test in congestive heart failure.
    Refsgaard J
    Eur Heart J; 2005 Apr; 26(8):749-50. PubMed ID: 15781434
    [No Abstract]   [Full Text] [Related]  

  • 6. Additive prognostic value of a cardiopulmonary exercise test score in patients with heart failure and intermediate risk.
    Ritt LE; Myers J; Stein R; Arena R; Guazzi M; Chase P; Bensimhon D; Ashley E; Cahalin LP; Forman DE
    Int J Cardiol; 2015 Jan; 178():262-4. PubMed ID: 25464266
    [No Abstract]   [Full Text] [Related]  

  • 7. High-density lipoprotein: why all the fuss?
    Mackness B; Mackness M
    Ann Clin Biochem; 2009 Jan; 46(Pt 1):5-7. PubMed ID: 19015220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise physiology and testing in adult patients with congenital heart disease.
    Buber J; Rhodes J
    Heart Fail Clin; 2014 Jan; 10(1):23-33. PubMed ID: 24275292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-mediated changes in high-density lipoprotein: impact on form and function.
    Blazek A; Rutsky J; Osei K; Maiseyeu A; Rajagopalan S
    Am Heart J; 2013 Sep; 166(3):392-400. PubMed ID: 24016485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.
    Hunter WG; McGarrah RW; Kelly JP; Khouri MG; Craig DM; Haynes C; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Coll Cardiol; 2019 Jan; 73(2):177-186. PubMed ID: 30654890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia, heart failure and exercise training.
    Sanchis-Gomar F; Banfi G; Pareja-Galeano H; Martinez-Bello V; Lippi G
    Int J Cardiol; 2013 May; 165(3):587-8. PubMed ID: 23031281
    [No Abstract]   [Full Text] [Related]  

  • 12. HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.
    Sirtori CR; Ruscica M; Calabresi L; Chiesa G; Giovannoni R; Badimon JJ
    Ann Med; 2019; 51(7-8):345-359. PubMed ID: 31729238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure.
    Chirinos JA; Zhao L; Jia Y; Frej C; Adamo L; Mann D; Shewale SV; Millar JS; Rader DJ; French B; Brandimarto J; Margulies KB; Parks JS; Wang Z; Seiffert DA; Fang J; Sweitzer N; Chistoffersen C; Dahlbäck B; Car BD; Gordon DA; Cappola TP; Javaheri A
    Circulation; 2020 May; 141(18):1463-1476. PubMed ID: 32237898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases].
    Babintseva YD; Camont L; Chapman J; Lhomme M; Karagodin VP; Kontush A; Orekhov AN
    Ter Arkh; 2016; 88(9):111-118. PubMed ID: 28635814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cradle-to-grave atherosclerosis: high density lipoprotein cholesterol.
    Glueck CJ
    J Am Coll Nutr; 1982; 1(1):41-8. PubMed ID: 7185843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the concentration and antiatherogenic activity of high-density lipoproteins.
    Barter PJ; Rye KA
    Curr Opin Lipidol; 2006 Aug; 17(4):399-403. PubMed ID: 16832163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of lipoprotein (a) and high density lipoproteins in transgenic mice.
    Rubin EM
    Atherosclerosis; 1994 Oct; 110 Suppl():S77-81. PubMed ID: 7857389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyunsaturated fatty acids supplementation impairs anti-oxidant high-density lipoprotein function in heart failure.
    Wurm R; Schrutka L; Hammer A; Moertl D; Berger R; Pavo N; Lang IM; Goliasch G; Huelsmann M; Distelmaier K
    Eur J Clin Invest; 2018 Sep; 48(9):e12998. PubMed ID: 30004123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
    Kitzman DW; Brubaker P; Morgan T; Haykowsky M; Hundley G; Kraus WE; Eggebeen J; Nicklas BJ
    JAMA; 2016 Jan; 315(1):36-46. PubMed ID: 26746456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the treatment of heart failure, faster may not always be better.
    Dickstein K
    Eur Heart J; 2002 Aug; 23(16):1239-41. PubMed ID: 12175659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.